AAAAAA

   
Results: 1-16 |
Results: 16
LACK OF CORRELATION BETWEEN C-ERBB-2 OVEREXPRESSION AND THE EFFECT OFDOSE-INTENSIFICATION OF ADJUVANT CHEMOTHERAPY IN HIGH-RISK BREAST-CANCER PATIENTS
Authors: THOMSSEN C UNTCH M KONECNY G LEBEAU A DETTMAR P SATTLER D KUHN W KAHLERT S HEPP H GRAEFF H JANICKE F
Citation: C. Thomssen et al., LACK OF CORRELATION BETWEEN C-ERBB-2 OVEREXPRESSION AND THE EFFECT OFDOSE-INTENSIFICATION OF ADJUVANT CHEMOTHERAPY IN HIGH-RISK BREAST-CANCER PATIENTS, European journal of cancer, 34, 1998, pp. 132-132
RANDOMIZED ADJUVANT TRIAL COMPARING 2 DOSE INTENSITIES OF EPIRUBICIN AND CYCLOPHOSPHAMIDE (EC) IN HIGH-RISK BREAST-CANCER
Authors: KONECNY G THOMSSEN C UNTCH M KAHLERT S KUHN W SATTLER D PICHE E LEBEAU A DETTMAR P GRAEFF H JANICKE F
Citation: G. Konecny et al., RANDOMIZED ADJUVANT TRIAL COMPARING 2 DOSE INTENSITIES OF EPIRUBICIN AND CYCLOPHOSPHAMIDE (EC) IN HIGH-RISK BREAST-CANCER, European journal of cancer, 34, 1998, pp. 164-164
UROKINASE-LIKE PLASMINOGEN-ACTIVATOR (UPA) AND PLASMINOGEN-ACTIVATOR INHIBITOR TYPE-1 (PAI-1) IN PRIMARY BREAST-CANCER - PREDICTIVE MARKERSFOR TAMOXIFEN RESISTANCE
Authors: KAHLERT S BOETTCHER B KONECNY G BAUERFEIND I NESTLEKRAEMLING C UNTCH M
Citation: S. Kahlert et al., UROKINASE-LIKE PLASMINOGEN-ACTIVATOR (UPA) AND PLASMINOGEN-ACTIVATOR INHIBITOR TYPE-1 (PAI-1) IN PRIMARY BREAST-CANCER - PREDICTIVE MARKERSFOR TAMOXIFEN RESISTANCE, European journal of cancer, 34, 1998, pp. 381-381
NEW DRUGS IN BREAST-CANCER THERAPY - CURR ENT POSITION AND FUTURE PERSPECTIVES
Authors: KONECNY G UNTCH M HEPP H
Citation: G. Konecny et al., NEW DRUGS IN BREAST-CANCER THERAPY - CURR ENT POSITION AND FUTURE PERSPECTIVES, Gynakologisch-geburtshilfliche Rundschau, 37(2), 1997, pp. 54-61
DOSE-INTENSIFIED VERSUS STANDARD CHEMOTHERAPY IN HIGH-RISK BREAST-CANCER PATIENTS - PRELIMINARY DATA OF A RANDOMIZED TRIAL
Authors: THOMSSEN C UNTCH M SCHILL E SATTLER D KONECNY G BAUERNFEIND P JANICKE F GRAEFF H
Citation: C. Thomssen et al., DOSE-INTENSIFIED VERSUS STANDARD CHEMOTHERAPY IN HIGH-RISK BREAST-CANCER PATIENTS - PRELIMINARY DATA OF A RANDOMIZED TRIAL, European journal of cancer, 33, 1997, pp. 662-662
MAPPING FROM DIGITAL SATELLITE IMAGE DATA WITH SPECIAL REFERENCE TO MOMS-02
Authors: KONECNY G SCHIEWE J
Citation: G. Konecny et J. Schiewe, MAPPING FROM DIGITAL SATELLITE IMAGE DATA WITH SPECIAL REFERENCE TO MOMS-02, ISPRS journal of photogrammetry and remote sensing, 51(4), 1996, pp. 173-181
ADEKOYA,OLAYINKA, 1945-1995 - OBITUARY
Authors: KONECNY G
Citation: G. Konecny, ADEKOYA,OLAYINKA, 1945-1995 - OBITUARY, ISPRS journal of photogrammetry and remote sensing, 51(1), 1996, pp. 49-50
PARADIGM CHANGES IN ISPRS FROM THE FIRST TO THE EIGHTEENTH CONGRESS IN VIENNA - KEYNOTE PAPER TO THE 18TH ISPRS CONGRESS, JULY 9, 1996
Authors: KONECNY G
Citation: G. Konecny, PARADIGM CHANGES IN ISPRS FROM THE FIRST TO THE EIGHTEENTH CONGRESS IN VIENNA - KEYNOTE PAPER TO THE 18TH ISPRS CONGRESS, JULY 9, 1996, Photogrammetric engineering and remote sensing, 62(10), 1996, pp. 1117
INTERIM ANALYSIS OF A PHASE-II STUDY OF EPIRUBICIN AND PACLITAXEL AS FIRST-LINE THERAPY IN PATIENTS WITH METASTATIC BREAST-CANCER
Authors: LUCK HJ THOMSSEN C DUBOIS A LISBOA BW UNTCH M KUHNLE H KONECNY G JANICKE F MEERPOHL HG LINDNER C HECKER D DIERGARTEN K
Citation: Hj. Luck et al., INTERIM ANALYSIS OF A PHASE-II STUDY OF EPIRUBICIN AND PACLITAXEL AS FIRST-LINE THERAPY IN PATIENTS WITH METASTATIC BREAST-CANCER, Seminars in oncology, 23(1), 1996, pp. 33-36
DETECTION OF TUMOR-CELLS IN THE BONE-MARROW OF BREAST-CANCER PATIENTSBY CYTOKERATIN-19 - REVERSE-TRANSCRIPTASE - POLYMERASE CHAIN-REACTION(RT-PCR)
Authors: NESTLEKRAMLING C UNTCH M HAGEN D FIELDS K FUNKE I KONECNY G
Citation: C. Nestlekramling et al., DETECTION OF TUMOR-CELLS IN THE BONE-MARROW OF BREAST-CANCER PATIENTSBY CYTOKERATIN-19 - REVERSE-TRANSCRIPTASE - POLYMERASE CHAIN-REACTION(RT-PCR), European journal of cancer, 31A, 1995, pp. 74-74
ADJUVANT HIGH-DOSE EPIRUBICIN AND CYCLOPHOSPHAMIDE WITH G-CSF SUPPORTIN PATIENTS WITH LOCALLY ADVANCED BREAST-CANCER
Authors: KONECNY G UNTCH M BAUERFEIND I PICHE E NESTLEKRAMLING C
Citation: G. Konecny et al., ADJUVANT HIGH-DOSE EPIRUBICIN AND CYCLOPHOSPHAMIDE WITH G-CSF SUPPORTIN PATIENTS WITH LOCALLY ADVANCED BREAST-CANCER, European journal of cancer, 31A, 1995, pp. 79-79
CAMBRIDGE CONFERENCE FOR NATIONAL MAPPING ORGANIZATIONS 1995 - JULY 25 AUGUST 1, 1995, CAMBRIDGE, UK
Authors: KONECNY G
Citation: G. Konecny, CAMBRIDGE CONFERENCE FOR NATIONAL MAPPING ORGANIZATIONS 1995 - JULY 25 AUGUST 1, 1995, CAMBRIDGE, UK, ISPRS journal of photogrammetry and remote sensing, 50(6), 1995, pp. 31-31
EARTH OBSERVATION IN EDUCATION AND TRAINING - EARSELS VIEWPOINT
Authors: KONECNY G VETRELLA S
Citation: G. Konecny et S. Vetrella, EARTH OBSERVATION IN EDUCATION AND TRAINING - EARSELS VIEWPOINT, International journal of remote sensing, 15(15), 1994, pp. 2970-2971
LOCAL SERUM APPLICATION - RESTORATION OF SUFFICIENT HOST-DEFENSE IN HUMAN PERITONITIS
Authors: BILLING AG FROHLICH D KONECNY G SCHILDBERG FW MACHLEIDT W FRITZ H JOCHUM M
Citation: Ag. Billing et al., LOCAL SERUM APPLICATION - RESTORATION OF SUFFICIENT HOST-DEFENSE IN HUMAN PERITONITIS, European journal of clinical investigation, 24(1), 1994, pp. 28-35
SUCCESSFUL PELVIC FLOOR TRAINING IN THE S TRESS-INCONTINENCE Q-TIP TEST - A PROGNOSTIC FACTOR
Authors: HESSE U VONOBERNITZ N ROMISCH M KONECNY G ANTHUBER S SCHUSSLER B
Citation: U. Hesse et al., SUCCESSFUL PELVIC FLOOR TRAINING IN THE S TRESS-INCONTINENCE Q-TIP TEST - A PROGNOSTIC FACTOR, Archives of gynecology and obstetrics, 254(1-4), 1993, pp. 506-507
PRETREATMENT IN-VITRO CHEMOSENSITIVITY IN GYNECOLOGICAL ONCOLOGY - USE OF THE ATP CHEMOSENSITIVITY ASSAY
Authors: UNTSCH M BLAIBL A SEVIN BU KONECNY G NESTLE K HEPP H
Citation: M. Untsch et al., PRETREATMENT IN-VITRO CHEMOSENSITIVITY IN GYNECOLOGICAL ONCOLOGY - USE OF THE ATP CHEMOSENSITIVITY ASSAY, Archives of gynecology and obstetrics, 254(1-4), 1993, pp. 1074-1076
Risultati: 1-16 |